Mersana Therapeutics (MRSN) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.5
-0.39
-0.27
-0.16

Details

Expected EPS
-0.178439
Actual EPS
-0.16
Surprise EPS
0.02
Surprise Percent
+10.33%

Description

Mersana Therapeutics (MRSN) has reported earnings of -0.16 per share for Q2 2024.

0 Comments

Share your thoughts